These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19926118)

  • 1. A review of 122 published outcomes of danaparoid anticoagulation for intermittent haemodialysis.
    Magnani HN
    Thromb Res; 2010 Apr; 125(4):e171-6. PubMed ID: 19926118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004.
    Magnani HN; Gallus A
    Thromb Haemost; 2006 Jun; 95(6):967-81. PubMed ID: 16732376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of clinical outcomes of 91 pregnancies in 83 women treated with danaparoid (Orgaran).
    Magnani HN
    Thromb Res; 2010 Apr; 125(4):297-302. PubMed ID: 19656552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of 51 pregnancies with danaparoid because of heparin intolerance.
    Lindhoff-Last E; Kreutzenbeck HJ; Magnani HN
    Thromb Haemost; 2005 Jan; 93(1):63-9. PubMed ID: 15630492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
    Castelino RL; Maddula M; Tarafdar S; Sud K; Kairaitis L
    Thromb Res; 2019 Aug; 180():70-73. PubMed ID: 31229923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
    Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
    Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Danaparoid in pregnancy in cases of heparin intolerance - use in 59 cases].
    Schindewolf M; Magnani HN; Lindhoff-Last E
    Hamostaseologie; 2007 May; 27(2):89-97. PubMed ID: 17479171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multidisciplinary consultation for the prescription of danaparoid in suspected heparin-induced thrombocytopenia].
    Verdy E; Debrix I; Benomar A; Becker A; Flahault A
    Presse Med; 2007 May; 36(5 Pt 1):786-93. PubMed ID: 17303370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s.
    Lubenow N; Warkentin TE; Greinacher A; Wessel A; Sloane DA; Krahn EL; Magnani HN
    Thromb Res; 2006; 117(5):507-15. PubMed ID: 15907979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R; Rachmimov R; Berliner S
    Harefuah; 1999 Mar; 136(5):361-4, 419. PubMed ID: 10914239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factor V Leiden mutation, a history of venous thrombosis and recurrent pregnancy losses.
    Schindewolf M; Lindhoff-Last E
    Thromb Haemost; 2008 Apr; 99(4):776-8. PubMed ID: 18392337
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of a low-molecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients.
    Lindhoff-Last E; Betz C; Bauersachs R
    Clin Appl Thromb Hemost; 2001 Oct; 7(4):300-4. PubMed ID: 11697713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E; Bauersachs R
    Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopaenia with thrombosis: a clinical outcome study.
    Chong BH; Gallus AS; Cade JF; Magnani H; Manoharan A; Oldmeadow M; Arthur C; Rickard K; Gallo J; Lloyd J; Seshadri P; Chesterman CN;
    Thromb Haemost; 2001 Nov; 86(5):1170-5. PubMed ID: 11816702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danaparoid in the prevention of thromboembolic complications.
    Skoutakis VA
    Ann Pharmacother; 1997; 31(7-8):876-87. PubMed ID: 9220051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of danaparoid (Orgaran) use in children.
    Bidlingmaier C; Magnani HN; Girisch M; Kurnik K
    Acta Haematol; 2006; 115(3-4):237-47. PubMed ID: 16549902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
    Emig U; Meyer T; Buchwald AB
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):965-8. PubMed ID: 9280716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment options for heparin-induced thrombocytopenia.
    Ortel TL; Chong BH
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
    Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
    Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.